• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铅对大鼠砷生物利用度和药代动力学的交互作用。

Interaction effects of lead on bioavailability and pharmacokinetics of arsenic in the rat.

机构信息

National Research Centre for Environmental Toxicity, The University of Queensland, 39 Kessels Rd, Coopers Plains, Brisbane, QLD, 4108, Australia,

出版信息

Environ Geochem Health. 2013 Dec;35(6):757-66. doi: 10.1007/s10653-013-9527-x. Epub 2013 Jun 1.

DOI:10.1007/s10653-013-9527-x
PMID:23728997
Abstract

Arsenic (As) and lead (Pb) are common contaminants found in mine waste materials. For an evidence-based risk assessment, it is important to better understand the potential interaction of mixed contaminants; and this interaction study was investigated in an in vivo rat model. Following co-administration of a fixed dose of As(V) as in sodium arsenate and different doses of Pb as lead acetate to Sprague-Dawley rats, blood arsenic concentration and bioavailability decreased. A decrease in As blood concentration when lead was co-administered was observed with increasing lead doses. Pharmacokinetic parameters for As in the blood showed faster absorption and elimination of this metalloid in the presence of Pb. The elimination half-life of As decreased from 67 days in As solo group to 27-30 with doses of Pb. Bioavailability of As was also decreased by 30-43 % in the presence of Pb. Decreased urinary excretion of Pb and tissue accumulation were also observed. It indicates lower absorption of As when co-administered with Pb. A probable explanation for these findings is that As co-administration with Pb could have resulted in the formation of less soluble lead arsenate. However, such an interaction between As and Pb could only explain about one-third of the variation when real mine waste materials containing both of these elements were administered to rats. This suggests that other effects from physical and chemical parameters could contribute to the bioavailability of arsenic in complex real environmental samples.

摘要

砷(As)和铅(Pb)是矿山废物中常见的污染物。为了进行基于证据的风险评估,了解混合污染物的潜在相互作用非常重要;本研究在体内大鼠模型中研究了这种相互作用。在向 Sprague-Dawley 大鼠共同给予固定剂量的砷酸钠中的 As(V)和不同剂量的醋酸铅后,血液中的砷浓度和生物利用度降低。当共同给予铅时,观察到随着铅剂量的增加,血液中砷的浓度降低。血液中砷的药代动力学参数显示,在 Pb 存在下,这种类金属的吸收和消除更快。As 的消除半衰期从 As 单独组的 67 天减少到 Pb 剂量为 27-30 天。Pb 的存在也使 As 的生物利用度降低了 30-43%。尿铅排泄减少和组织积累也观察到。这表明当与 Pb 共同给予时,As 的吸收减少。这些发现的一个可能解释是,As 与 Pb 共同给予可能导致形成较少可溶性的砷酸铅。然而,当将含有这两种元素的实际矿山废物给予大鼠时,这种 As 和 Pb 之间的相互作用仅能解释约三分之一的变化。这表明物理和化学参数的其他影响可能会影响复杂实际环境样品中砷的生物利用度。

相似文献

1
Interaction effects of lead on bioavailability and pharmacokinetics of arsenic in the rat.铅对大鼠砷生物利用度和药代动力学的交互作用。
Environ Geochem Health. 2013 Dec;35(6):757-66. doi: 10.1007/s10653-013-9527-x. Epub 2013 Jun 1.
2
Bioavailability and pharmacokinetics of arsenic are influenced by the presence of cadmium.砷的生物利用度和药代动力学受镉的存在影响。
Chemosphere. 2014 Oct;112:203-9. doi: 10.1016/j.chemosphere.2014.04.013. Epub 2014 May 13.
3
Absolute bioavailability of lead acetate and mining waste lead in rats.醋酸铅和采矿废铅在大鼠体内的绝对生物利用度。
Toxicology. 1994 Jul 1;91(2):151-63. doi: 10.1016/0300-483x(94)90141-4.
4
Relative oral bioavailability of arsenic from contaminated soils measured in the cynomolgus monkey.食蟹猴体内测定的受污染土壤中砷的相对口服生物利用度。
Toxicol Sci. 2007 Jan;95(1):281-8. doi: 10.1093/toxsci/kfl117. Epub 2006 Sep 27.
5
Influence of co-contaminant exposure on the absorption of arsenic, cadmium and lead.共污染物暴露对砷、镉和铅吸收的影响。
Chemosphere. 2017 Feb;168:658-666. doi: 10.1016/j.chemosphere.2016.11.010. Epub 2016 Nov 9.
6
Relative bioavailability and bioaccessibility and speciation of arsenic in contaminated soils.污染土壤中砷的相对生物有效性和生物可及性及形态。
Environ Health Perspect. 2011 Nov;119(11):1629-34. doi: 10.1289/ehp.1003352. Epub 2011 Jul 13.
7
Measurement of arsenic relative bioavailability in swine.猪砷相对生物利用度的测定。
J Toxicol Environ Health A. 2013;76(7):449-57. doi: 10.1080/15287394.2013.771562.
8
Influence of sample matrix on the bioavailability of arsenic, cadmium and lead during co-contaminant exposure.共存污染物暴露过程中样品基质对砷、镉和铅生物可给性的影响。
Sci Total Environ. 2017 Oct 1;595:660-665. doi: 10.1016/j.scitotenv.2017.04.036. Epub 2017 Apr 10.
9
In vitro physiologically based extraction test (PBET) and bioaccessibility of arsenic and lead from various mine waste materials.体外基于生理学的提取试验(PBET)以及各种矿山废料中砷和铅的生物可及性
J Toxicol Environ Health A. 2007 Oct;70(19):1700-11. doi: 10.1080/15287390701434901.
10
Evaluating lead bioavailability data by means of a physiologically based lead kinetic model.通过基于生理学的铅动力学模型评估铅生物利用度数据。
Fundam Appl Toxicol. 1996 Jan;29(1):63-70.

引用本文的文献

1
In Vitro and In Vivo Testing to Determine Cd Bioaccessibility and Bioavailability in Contaminated Rice in Relation to Mouse Chow.在与鼠粮相关的情况下,对污染大米中 Cd 的生物可及性和生物利用度进行体外和体内测试。
Int J Environ Res Public Health. 2019 Mar 10;16(5):871. doi: 10.3390/ijerph16050871.
2
Exposure to Mixtures of Metals and Neurodevelopmental Outcomes: A Multidisciplinary Review Using an Adverse Outcome Pathway Framework.金属混合物暴露与神经发育结局:使用不良结局途径框架的多学科综述
Risk Anal. 2015 Jun;35(6):971-1016. doi: 10.1111/risa.12425. Epub 2015 Jun 10.

本文引用的文献

1
Effects of water hardness and alkalinity on the toxicity of uranium to a tropical freshwater hydra (Hydra viridissima).水的硬度和碱度对热带淡水水螅(Hydra viridissima)铀毒性的影响。
Biomarkers. 2001;6(1):45-51. doi: 10.1080/135475001452788.
2
Dissolved organic carbon reduces uranium bioavailability and toxicity. 1. Characterization of an aquatic fulvic acid and its complexation with uranium[VI].溶解有机碳会降低铀的生物利用度和毒性。1. 一种水生富里酸的特性及其与铀(VI)的络合作用。
Environ Sci Technol. 2011 Apr 1;45(7):3075-81. doi: 10.1021/es103330w. Epub 2011 Feb 25.
3
Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study.
孟加拉国(HEALS)的饮用水砷暴露与全因和慢性病死亡率:一项前瞻性队列研究。
Lancet. 2010 Jul 24;376(9737):252-8. doi: 10.1016/S0140-6736(10)60481-3. Epub 2010 Jun 18.
4
Distribution and speciation of arsenic after intravenous administration of monomethylmonothioarsonic acid in rats.静脉注射单甲基单硫代砷酸后在大鼠体内的砷分布和形态。
Chemosphere. 2010 Sep;81(2):206-13. doi: 10.1016/j.chemosphere.2010.06.043. Epub 2010 Jul 1.
5
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.PKSolver:一个在 Microsoft Excel 中进行药代动力学和药效动力学数据分析的插件程序。
Comput Methods Programs Biomed. 2010 Sep;99(3):306-14. doi: 10.1016/j.cmpb.2010.01.007. Epub 2010 Feb 21.
6
Chronic Arsenic poisoning.
J Pak Med Assoc. 2009 Feb;59(2):105-7.
7
Principles and application of an in vivo swine assay for the determination of arsenic bioavailability in contaminated matrices.用于测定污染基质中砷生物有效性的体内猪试验的原理与应用
Environ Geochem Health. 2009 Apr;31 Suppl 1:167-77. doi: 10.1007/s10653-008-9237-y. Epub 2008 Dec 23.
8
Arsenic metabolism and thioarsenicals in hamsters and rats.仓鼠和大鼠体内的砷代谢与硫代砷化合物
Chem Res Toxicol. 2007 Apr;20(4):616-24. doi: 10.1021/tx700038x. Epub 2007 Mar 24.
9
Human health effects from chronic arsenic poisoning--a review.慢性砷中毒对人体健康的影响——综述
J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006;41(10):2399-428. doi: 10.1080/10934520600873571.
10
Chronic arsenic exposure and adverse pregnancy outcomes in bangladesh.孟加拉国慢性砷暴露与不良妊娠结局
Epidemiology. 2005 Jan;16(1):82-6. doi: 10.1097/01.ede.0000147105.94041.e6.